148 related articles for article (PubMed ID: 1689578)
21. Effects of two distamycin-ellipticine hybrid molecules on topoisomerase I and II mediated DNA cleavage: relation to cytotoxicity.
Riou JF; Grondard L; Naudin A; Bailly C
Biochem Pharmacol; 1995 Jul; 50(3):424-8. PubMed ID: 7646545
[TBL] [Abstract][Full Text] [Related]
22. DNA damage and cell killing by camptothecin and its derivative in human leukemia HL-60 cells.
Yoshida A; Ueda T; Wano Y; Nakamura T
Jpn J Cancer Res; 1993 May; 84(5):566-73. PubMed ID: 8391526
[TBL] [Abstract][Full Text] [Related]
23. Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase I.
Covey JM; Jaxel C; Kohn KW; Pommier Y
Cancer Res; 1989 Sep; 49(18):5016-22. PubMed ID: 2548707
[TBL] [Abstract][Full Text] [Related]
24. [2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding to transcription factor Sp1.
Baraldi PG; Cacciari B; Guiotto A; Romagnoli R; Spalluto G; Leoni A; Bianchi N; Feriotto G; Rutigliano C; Mischiati C; Gambari R
Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1219-29. PubMed ID: 11097052
[TBL] [Abstract][Full Text] [Related]
25. Comparison of topoisomerase I inhibition, DNA damage, and cytotoxicity of camptothecin derivatives presently in clinical trials.
Tanizawa A; Fujimori A; Fujimori Y; Pommier Y
J Natl Cancer Inst; 1994 Jun; 86(11):836-42. PubMed ID: 8182764
[TBL] [Abstract][Full Text] [Related]
26. Distamycin inhibition of topoisomerase I-DNA interaction: a mechanistic analysis.
Mortensen UH; Stevnsner T; Krogh S; Olesen K; Westergaard O; Bonven BJ
Nucleic Acids Res; 1990 Apr; 18(8):1983-9. PubMed ID: 2159632
[TBL] [Abstract][Full Text] [Related]
27. Production of protein-associated DNA breaks by 8-methoxycaffeine, caffeine and 8-chlorocaffeine in isolated nuclei from L1210 cells: comparison with those produced by topoisomerase II inhibitors.
Russo P; Poggi L; Parodi S; Pedrini AM; Kohn KW; Pommier Y
Carcinogenesis; 1991 Oct; 12(10):1781-90. PubMed ID: 1657426
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional regulation of differentiation, selective toxicity and ATGCAAAT binding of bisbenzimidazole derivatives in human melanoma cells.
Wong SS; Sturm RA; Michel J; Zhang XM; Danoy PA; McGregor K; Jacobs JJ; Kaushal A; Dong Y; Dunn IS
Biochem Pharmacol; 1994 Mar; 47(5):827-37. PubMed ID: 7510966
[TBL] [Abstract][Full Text] [Related]
29. A role of DNA topoisomerases in the active dissociation of DNA minor groove-ligand complexes. A flow cytometric study of inhibitor effects.
Smith PJ; Debenham PG; Watson JV
Mutat Res; 1989 Mar; 217(2):163-72. PubMed ID: 2537463
[TBL] [Abstract][Full Text] [Related]
30. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin.
Hsiang YH; Liu LF
Cancer Res; 1988 Apr; 48(7):1722-6. PubMed ID: 2832051
[TBL] [Abstract][Full Text] [Related]
31. Inhibiting transcription factor/DNA complexes using fluorescent microgonotropens (FMGTs).
White CM; Satz AL; Gawron LS; Bruice TC; Beerman TA
Biochim Biophys Acta; 2002 Feb; 1574(1):100-8. PubMed ID: 11955618
[TBL] [Abstract][Full Text] [Related]
32. Topoisomerase I-mediated DNA cleavage induced by the minor groove-directed binding of bibenzimidazoles to a distal site.
Khan QA; Pilch DS
J Mol Biol; 2007 Jan; 365(3):561-9. PubMed ID: 17095016
[TBL] [Abstract][Full Text] [Related]
33. Effects of DAPI on human leukocytes in vitro.
Rocchi A; Di Castro M; Prantera G
Cytogenet Cell Genet; 1979; 23(4):250-4. PubMed ID: 87292
[TBL] [Abstract][Full Text] [Related]
34. Distamycin-induced inhibition of formation of a nucleoprotein complex between the terminase small subunit G1P and the non-encapsidated end (pacL site) of Bacillus subtilis bacteriophage SPP1.
Chai S; Alsonso JC
Nucleic Acids Res; 1996 Jan; 24(2):282-8. PubMed ID: 8628651
[TBL] [Abstract][Full Text] [Related]
35. The effects of a benzoic acid mustard derivative of distamycin A (FCE 24517) and related minor groove-binding distamycin analogues on the activity of major groove-binding alkylating agents.
Coley HM; Mongelli N; D'Incalci M
Biochem Pharmacol; 1993 Feb; 45(3):619-26. PubMed ID: 8442762
[TBL] [Abstract][Full Text] [Related]
36. Topoisomerase II-mediated DNA damage produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and related acridines in L1210 cells and isolated nuclei: relation to cytotoxicity.
Covey JM; Kohn KW; Kerrigan D; Tilchen EJ; Pommier Y
Cancer Res; 1988 Feb; 48(4):860-5. PubMed ID: 2827887
[TBL] [Abstract][Full Text] [Related]
37. Effect of camptothecin and adriamycin on bleomycin-induced tritiated thymidine triphosphate incorporation in a rat nuclear system.
Sartiano GP; Cotezee ML; Klein K; Ove P
J Natl Cancer Inst; 1977 May; 58(5):1357-64. PubMed ID: 67212
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional regulation of topoisomerase II alpha at confluence and pharmacological modulation of expression by bis-benzimidazole drugs.
Tolner B; Hartley JA; Hochhauser D
Mol Pharmacol; 2001 Apr; 59(4):699-706. PubMed ID: 11259613
[TBL] [Abstract][Full Text] [Related]
39. Influence of minor groove binders on the eukaryotic topoisomerase II cleavage reaction with 41 base pair model oligonucleotides.
Bell A; Kittler L; Löber G; Zimmer C
Invest New Drugs; 1996; 13(4):271-84. PubMed ID: 8824345
[TBL] [Abstract][Full Text] [Related]
40. Assignment of DNA binding sites for 4',6-diamidine-2-phenylindole and bisbenzimide (Hoechst 33258). A comparative footprinting study.
Portugal J; Waring MJ
Biochim Biophys Acta; 1988 Feb; 949(2):158-68. PubMed ID: 2449244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
